Reviewing ReWalk Robotics (RWLK) & Its Rivals

ReWalk Robotics (NASDAQ: RWLK) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare ReWalk Robotics to related companies based on the strength of its profitability, valuation, earnings, analyst recommendations, dividends, risk and institutional ownership.

Institutional & Insider Ownership

How to Become a New Pot Stock Millionaire

2.5% of ReWalk Robotics shares are held by institutional investors. Comparatively, 54.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 13.7% of ReWalk Robotics shares are held by insiders. Comparatively, 11.2% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings for ReWalk Robotics and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReWalk Robotics 1 0 4 0 2.60
ReWalk Robotics Competitors 126 702 1249 52 2.58

ReWalk Robotics currently has a consensus target price of $2.80, indicating a potential upside of 154.55%. As a group, “Surgical appliances & supplies” companies have a potential upside of 4.74%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, equities analysts plainly believe ReWalk Robotics is more favorable than its rivals.


This table compares ReWalk Robotics and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReWalk Robotics -318.81% -678.44% -85.08%
ReWalk Robotics Competitors -284.95% -50.78% -16.25%

Risk and Volatility

ReWalk Robotics has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. Comparatively, ReWalk Robotics’ rivals have a beta of 0.84, suggesting that their average stock price is 16% less volatile than the S&P 500.

Valuation and Earnings

This table compares ReWalk Robotics and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ReWalk Robotics $7.75 million -$24.71 million -1.11
ReWalk Robotics Competitors $1.33 billion $194.31 million 22.38

ReWalk Robotics’ rivals have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


ReWalk Robotics rivals beat ReWalk Robotics on 8 of the 12 factors compared.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with's FREE daily email newsletter.

Leave a Reply